Incyte Corp (INCY)

Add to Watchlists

Create an Alert

Quickflows

90.42 +0.48 +0.53% NASDAQ Sep 17, 20:00 USD

Incyte News

Wire

Headline

Time (ET)
Yahoo

Eli Lilly, Amgen Teaming Up On Covid-19 Treatments

09/17 16:31
Yahoo

Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas

09/17 16:03
MT Newswires

Eli Lilly's COVID-19 Combination Trial Meets Primary Endpoint of Lowering Recovery Time; Plans Emergency Use Authorization Filing

09/17 14:28
Yahoo

Lilly and Pfizer Are Testing Treatments for Hospitalized Covid Patients

09/16 13:57
Yahoo

Incyte Corporation (INCY) Fell Out Of Favor With Hedge Funds

09/15 20:43
Yahoo

Gilead Makes Its Biggest Buy Ever And Gets A 'Flagship' Cancer Drug

09/14 16:38
Yahoo

Eli Lilly, Incyte Combine Covid Drug With Gilead's, Post Positive Data

09/14 16:31
Yahoo

Balloons at Macy’s Thanksgiving Day Parade Will Be Rigged to Special Vehicles

09/14 15:15
MT Newswires

Eli Lilly, Incyte Report Positive Data from Trial of Baricitinib, Remdesivir Combination to Treat COVID-19

09/14 08:59
Yahoo

Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time

09/14 07:48
SA Breaking News

Lilly's baricitinib shows positive action in hospitalized COVID-19 patients

09/14 07:17
PR Newswire

Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial

09/14 06:30
Business Wire

Incyte Announces Recipient of the Inaugural Incyte Ingenuity Award to Recognize Innovative Solutions that Address Needs in the GVHD Community

09/09 10:05
Yahoo

Analyst Report: Incyte Corporation

09/04 18:28
MT Newswires

Calithera Biosciences Cancels License Agreement With Incyte

09/04 10:05
SA Breaking News

Calithera nixes 2017 collaboration deal with Incyte

09/04 08:40
Yahoo

Incyte (INCY) Down 2.2% Since Last Earnings Report: Can It Rebound?

09/03 11:31
MT Newswires

Incyte Says Data Showed Positive Overall Response Rate for Tabrecta in Patients With Non-Small Cell Lung Cancer

09/03 03:51
Business Wire

Incyte Announces Pivotal GEOMETRY mono-1 Study Results of Capmatinib (Tabrecta™) in Patients with METex14 Metastatic Non-Small Cell Lung Cancer Published in NEJM

09/02 17:04
Business Wire

Incyte to Present at Upcoming Investor Conference

09/01 08:00

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial

{{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.